Suowen Xu
Title
Cited by
Cited by
Year
Cardiovascular actions and therapeutic potential of tanshinone IIA
S Gao, Z Liu, H Li, PJ Little, P Liu, S Xu
Atherosclerosis 220 (1), 3-10, 2012
2662012
Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation
D Kamato, ML Burch, TJ Piva, HB Rezaei, MA Rostam, S Xu, W Zheng, ...
Cellular signalling 25 (10), 2017-2024, 2013
2482013
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
S Xu, S Ogura, J Chen, PJ Little, J Moss, P Liu
Cellular and Molecular Life Sciences 70 (16), 2859-2872, 2013
2112013
Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway
Q Jiang, P Liu, X Wu, W Liu, X Shen, T Lan, S Xu, J Peng, X Xie, H Huang
Molecular and cellular endocrinology 331 (1), 34-40, 2011
1352011
Antioxidants in cardiovascular therapy: panacea or false hope?
K Goszcz, SJ Deakin, GG Duthie, D Stewart, SJ Leslie, IL Megson
Frontiers in cardiovascular medicine 2, 29, 2015
1222015
Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-oxLDL uptake
S Xu, Y Huang, Y Xie, T Lan, K Le, J Chen, S Chen, S Gao, X Xu, X Shen, ...
Cytotechnology 62 (5), 473-481, 2010
1152010
Tanshinone II-A: new perspectives for old remedies
S Xu, P Liu
Expert opinion on therapeutic patents 23 (2), 149-153, 2013
1132013
Cryptotanshinone suppressed inflammatory cytokines secretion in RAW264. 7 macrophages through inhibition of the NF-κB and MAPK signaling pathways
S Tang, XY Shen, HQ Huang, SW Xu, Y Yu, CH Zhou, SR Chen, K Le, ...
Inflammation 34 (2), 111-118, 2011
1032011
Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet
S Xu, PJ Little, T Lan, Y Huang, K Le, X Wu, X Shen, H Huang, Y Cai, ...
Archives of Biochemistry and Biophysics 515 (1-2), 72-79, 2011
862011
Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK–S1P signaling pathway
T Lan, X Shen, P Liu, W Liu, S Xu, X Xie, Q Jiang, W Li, H Huang
Archives of biochemistry and biophysics 502 (2), 112-120, 2010
832010
Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation
S Xu, Z Liu, Y Huang, K Le, F Tang, H Huang, S Ogura, PJ Little, X Shen, ...
Translational Research 160 (2), 114-124, 2012
792012
Salvia miltiorrhiza Burge (Danshen): A golden herbal medicine in cardiovascular therapeutics
Z Li, S Xu, P Liu
Acta Pharmacologica Sinica 39 (5), 802-824, 2018
782018
Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis
S Xu, Z Liu, P Liu
International journal of cardiology 172 (2), 313-317, 2014
762014
Tanshinone IIA attenuates atherosclerosis in ApoE−/− mice through down-regulation of scavenger receptor expression
FT Tang, Y Cao, TQ Wang, LJ Wang, J Guo, XS Zhou, S Xu, WH Liu, ...
European journal of pharmacology 650 (1), 275-284, 2011
762011
Tanshinone IIA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1
Z Liu, J Wang, E Huang, S Gao, H Li, J Lu, K Tian, PJ Little, X Shen, S Xu, ...
Journal of lipid research 55 (2), 201-213, 2014
752014
Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells
T Lan, W Liu, X Xie, S Xu, K Huang, J Peng, X Shen, P Liu, L Wang, P Xia, ...
Molecular Endocrinology 25 (12), 2094-2105, 2011
662011
Icariin derivative inhibits inflammation through suppression of p38 mitogen-activated protein kinase and nuclear factor-κB pathways
SR Chen, XZ Xu, YH Wang, JW Chen, SW Xu, LQ Gu, PQ Liu
Biological and Pharmaceutical Bulletin 33 (8), 1307-1313, 2010
662010
Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice
D Halim, MP Wilson, D Oliver, E Brosens, JBGM Verheij, Y Han, V Nanda, ...
Proceedings of the National Academy of Sciences 114 (13), E2739-E2747, 2017
642017
Poly (ADP‐ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications
S Xu, P Bai, PJ Little, P Liu
Medicinal research reviews 34 (3), 644-675, 2014
612014
Atheroprotective effects and molecular targets of tanshinones derived from herbal medicine danshen
J Fang, PJ Little, S Xu
Medicinal research reviews 38 (1), 201-228, 2018
532018
The system can't perform the operation now. Try again later.
Articles 1–20